Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 645

Similar articles for PubMed (Select 18566246)

1.

Histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in clear cell sarcoma models.

Liu S, Cheng H, Kwan W, Lubieniecka JM, Nielsen TO.

Mol Cancer Ther. 2008 Jun;7(6):1751-61. doi: 10.1158/1535-7163.MCT-07-0560.

2.

Romidepsin for the treatment of non-Hodgkin's lymphoma.

Yazbeck VY, Grant S.

Expert Opin Investig Drugs. 2015 Jul;24(7):965-79. doi: 10.1517/13543784.2015.1041586. Epub 2015 May 4.

PMID:
25936363
3.

Novel histone deacetylase inhibitors induce growth arrest, apoptosis, and differentiation in sarcoma cancer stem cells.

Di Pompo G, Salerno M, Rotili D, Valente S, Zwergel C, Avnet S, Lattanzi G, Baldini N, Mai A.

J Med Chem. 2015 May 14;58(9):4073-9. doi: 10.1021/acs.jmedchem.5b00126. Epub 2015 Apr 30.

PMID:
25905694
4.

The importance of being dead: cell death mechanisms assessment in anti-sarcoma therapy.

Rello-Varona S, Herrero-Martín D, Lagares-Tena L, López-Alemany R, Mulet-Margalef N, Huertas-Martínez J, Garcia-Monclús S, García Del Muro X, Muñoz-Pinedo C, Tirado OM.

Front Oncol. 2015 Apr 7;5:82. doi: 10.3389/fonc.2015.00082. eCollection 2015. Review.

5.

Correction: Combining PCI-24781, a Novel Histone Deacetylase Inhibitor, with Chemotherapy for the Treatment of Soft Tissue Sarcoma.

[No authors listed]

Clin Cancer Res. 2015 Apr 1;21(7):1774-5. doi: 10.1158/1078-0432.CCR-15-0351. No abstract available.

PMID:
25833311
6.

Clear cell sarcoma-like tumor of the gastrointestinal tract: an evolving entity.

Wang J, Thway K.

Arch Pathol Lab Med. 2015 Mar;139(3):407-12. doi: 10.5858/arpa.2013-0547-RS. Review.

PMID:
25724038
7.

Chemotherapy is getting 'smarter'.

Mehrling T.

Future Oncol. 2015 Feb;11(4):549-52. doi: 10.2217/fon.14.248. No abstract available.

PMID:
25686110
8.

A phase II study of SB939, a novel pan-histone deacetylase inhibitor, in patients with translocation-associated recurrent/metastatic sarcomas-NCIC-CTG IND 200†.

Chu QS, Nielsen TO, Alcindor T, Gupta A, Endo M, Goytain A, Xu H, Verma S, Tozer R, Knowling M, Bramwell VB, Powers J, Seymour LK, Eisenhauer EA.

Ann Oncol. 2015 May;26(5):973-81. doi: 10.1093/annonc/mdv033. Epub 2015 Jan 28.

PMID:
25632070
9.

Mechanism of N-Acylthiourea-mediated activation of human histone deacetylase 8 (HDAC8) at molecular and cellular levels.

Singh RK, Cho K, Padi SK, Yu J, Haldar M, Mandal T, Yan C, Cook G, Guo B, Mallik S, Srivastava DK.

J Biol Chem. 2015 Mar 6;290(10):6607-19. doi: 10.1074/jbc.M114.600627. Epub 2015 Jan 20.

PMID:
25605725
10.

Biochemical, biological and structural properties of romidepsin (FK228) and its analogs as novel HDAC/PI3K dual inhibitors.

Saijo K, Imamura J, Narita K, Oda A, Shimodaira H, Katoh T, Ishioka C.

Cancer Sci. 2015 Feb;106(2):208-15. doi: 10.1111/cas.12585. Epub 2015 Jan 28.

PMID:
25492515
11.

Photoclinic. Clear cell sarcoma.

Afshar A, Ilkhanizadeh B.

Arch Iran Med. 2014 Dec;17(12):853-4. doi: 0141712/AIM.0014. No abstract available.

12.

Absence of 19 known hotspot oncogenic mutations in soft tissue clear cell sarcoma: two cases report with review of the literature.

Liu C, Ren Y, Li X, Cao Y, Chen Y, Cui X, Li L, Li F.

Int J Clin Exp Pathol. 2014 Jul 15;7(8):5242-9. eCollection 2014. Review.

13.

Histone deacetylase inhibitor-mediated cell death is distinct from its global effect on chromatin.

Luchenko VL, Litman T, Chakraborty AR, Heffner A, Devor C, Wilkerson J, Stein W, Robey RW, Bangiolo L, Levens D, Bates SE.

Mol Oncol. 2014 Dec;8(8):1379-92. doi: 10.1016/j.molonc.2014.05.001. Epub 2014 May 28.

PMID:
24954856
14.

Establishment of a novel clear cell sarcoma cell line (Hewga-CCS), and investigation of the antitumor effects of pazopanib on Hewga-CCS.

Outani H, Tanaka T, Wakamatsu T, Imura Y, Hamada K, Araki N, Itoh K, Yoshikawa H, Naka N.

BMC Cancer. 2014 Jun 19;14:455. doi: 10.1186/1471-2407-14-455.

15.

NSD3-NUT fusion oncoprotein in NUT midline carcinoma: implications for a novel oncogenic mechanism.

French CA, Rahman S, Walsh EM, Kühnle S, Grayson AR, Lemieux ME, Grunfeld N, Rubin BP, Antonescu CR, Zhang S, Venkatramani R, Dal Cin P, Howley PM.

Cancer Discov. 2014 Aug;4(8):928-41. doi: 10.1158/2159-8290.CD-14-0014. Epub 2014 May 29.

16.

The novel histone deacetylase inhibitor thailandepsin A inhibits anaplastic thyroid cancer growth.

Weinlander E, Somnay Y, Harrison AD, Wang C, Cheng YQ, Jaskula-Sztul R, Yu XM, Chen H.

J Surg Res. 2014 Jul;190(1):191-7. doi: 10.1016/j.jss.2014.02.042. Epub 2014 Feb 28.

PMID:
24679699
17.

Synergistic anticancer activity of valproate combined with nicotinamide enhances anti-proliferation response and apoptosis in MIAPaca2 cells.

Jafary H, Ahmadian S, Soleimani M.

Mol Biol Rep. 2014 Jun;41(6):3801-12. doi: 10.1007/s11033-014-3246-y. Epub 2014 Mar 5.

PMID:
24595447
18.

Total synthesis of burkholdacs A and B and 5,6,20-tri-epi-burkholdac A: HDAC inhibition and antiproliferative activity.

Fukui Y, Narita K, Dan S, Yamori T, Ito A, Yoshida M, Katoh T.

Eur J Med Chem. 2014 Apr 9;76:301-13. doi: 10.1016/j.ejmech.2014.02.044. Epub 2014 Feb 18.

PMID:
24589486
19.

An aza-macrocycle containing maltolic side-arms (maltonis) as potential drug against human pediatric sarcomas.

Guerzoni C, Amatori S, Giorgi L, Manara MC, Landuzzi L, Lollini PL, Tassoni A, Balducci M, Manfrini M, Pratelli L, Serra M, Picci P, Magnani M, Fusi V, Fanelli M, Scotlandi K.

BMC Cancer. 2014 Feb 27;14:137. doi: 10.1186/1471-2407-14-137.

20.

An unusual case of clear cell sarcoma presenting as multiple abdominal masses confirmed by RT-PCR.

Hui M, Uppin S, Mehta J, Krishnamani K, Gandhi LV.

South Asian J Cancer. 2013 Jul;2(3):152. doi: 10.4103/2278-330X.114139. No abstract available.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk